Predicting overall survival in glioblastoma patients using machine learning: an analysis of treatment efficacy and patient prognosis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Machine learning accurately predicts glioblastoma (GBM) patient survival using clinical and molecular data. XGBoost model identified MGMT promoter methylation and Karnofsky Performance Status (KPS) as key survival predictors.
Area Of Science
- Neuro-oncology
- Computational biology
- Biostatistics
Background
- Glioblastoma (GBM) is an aggressive brain tumor with challenging survival prediction due to heterogeneity.
- Accurate survival prediction is crucial for optimizing GBM treatment and improving patient outcomes.
Purpose Of The Study
- To develop and evaluate machine learning (ML) models for predicting glioblastoma patient survival.
- To identify key prognostic markers influencing GBM patient survival.
Main Methods
- Utilized metadata from 135 GBM patients, including demographic, clinical (Karnofsky Performance Status - KPS), and molecular (MGMT promoter methylation, EGFR amplification) variables.
- Employed six ML models (XGBoost, Random Forests, SVM, ANN, Extra Trees, KNN) for survival classification, with data preprocessing and hyperparameter optimization.
- Assessed model performance using ROC-AUC and accuracy metrics.
Main Results
- The XGBoost model achieved the highest predictive accuracy (ROC-AUC 0.90, accuracy 0.78).
- Ensemble models demonstrated superior performance compared to simpler classifiers.
- MGMT promoter methylation and KPS were identified as significant prognostic markers.
Conclusions
- Machine learning applied to GBM metadata provides a robust approach for survival prediction.
- ML models can enhance clinical decision-making and personalized treatment strategies for GBM patients.
- The study emphasizes the potential of ML for accurate, reliable, and interpretable GBM survival forecasting.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...